Gilead shows its belief in its partner's cancer treatment with a $7.8 billion buyout
吉利德科学吉利德科学(US:GILD) MarketWatch·2026-02-23 20:13

交易概述 - 吉利德科学公司同意收购其尚未持有的生物技术公司Arcellx的全部股份 [1] - 该交易股权价值为78亿美元 [1] 市场反应 - Arcellx股价在周一早盘交易中大幅上涨 [1] - 股价走势指向刷新历史纪录 [1]

Gilead shows its belief in its partner's cancer treatment with a $7.8 billion buyout - Reportify